Computer models to predict cure and guide treatment decisions
Machine Learning-Based Predictive Models for Disease Cure and Computationally Efficient Methods in High-Dimensional Settings
This work builds computer tools that use patient data to predict who is likely cured and who may need more treatment so doctors can avoid unnecessary high‑intensity therapies.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Arlington NIH-funded |
| Lab location | 1 site (Arlington, United States) |
| Project ID | NIH-11323047 on NIH RePORTER |
What this research studies
From your perspective, researchers will build fast machine‑learning tools that look at many pre‑treatment health details and follow‑up outcomes to guess whether you are likely cured. The team plans to design methods that work well with very large sets of medical features and that are more reliable than current models. They will compare these new approaches to existing ones and create user‑friendly software so hospitals can run the tools without deep programming know‑how. The goal is to test and validate the models using real clinical data so the tools can be useful in everyday care.
Who could benefit from this research
Good fit: Ideal candidates would be people with early‑stage disease who have detailed pre‑treatment clinical information and follow‑up (survival) data available for model training or validation.
Not a fit: Patients without adequate electronic medical records, those with advanced‑stage disease not represented in the data, or conditions outside the tested disease types are unlikely to benefit directly from these models.
Why it matters
Potential benefit: If successful, these tools could help avoid unnecessary aggressive treatments for patients who are already cured and spot those who need earlier intervention.
How similar studies have performed: Previous machine‑learning approaches have shown promise for predicting outcomes, but many existing models struggle with very high‑dimensional data and clinical implementation, so this work aims to improve on those gaps.
Where this research is happening
Arlington, United States
- University of Texas Arlington — Arlington, United States (Active)
Researchers
- Principal investigator: Pal, Suvra — University of Texas Arlington
- Study coordinator: Pal, Suvra
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.